Try it
Pharmacology · Antitubercular drugs: BPaLM regimen
Sample itemUnder current programme guidance, a patient with rifampicin-resistant pulmonary tuberculosis with fluoroquinolone-susceptible disease is eligible for a six-month all-oral regimen. Which drugs make up BPaLM?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. Bedaquiline, pretomanid, linezolid and moxifloxacin
BPaLM combines bedaquiline, pretomanid, linezolid and moxifloxacin for six months in eligible rifampicin-resistant TB. Linezolid toxicities include myelosuppression and neuropathy, and injectable agents have been removed from the preferred regimens.
Option by option
A. Bedaquiline, pretomanid, linezolid and moxifloxacin (correct)
Correct. This is the BPaLM combination.
B. Streptomycin, cycloserine, ethionamide and PAS
These are older second-line drugs.
C. Bedaquiline, kanamycin, ethambutol and pyrazinamide
Kanamycin injectables are no longer used in this regimen.
D. Isoniazid, rifampicin, pyrazinamide and ethambutol
That is the first-line regimen for drug-sensitive TB.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?